Previous Close | 0.6798 |
Open | 0.6896 |
Bid | 0.6382 x 100 |
Ask | 0.6972 x 100 |
Day's Range | 0.6600 - 0.7049 |
52 Week Range | 0.5000 - 9.2400 |
Volume | |
Avg. Volume | 282,159 |
Market Cap | 33.441M |
Beta (5Y Monthly) | 1.14 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.0500 |
Earnings Date | May 13, 2024 - May 17, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.00 |
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced the availability of its definitive proxy materials for its 2024 Annual Meeting to be held on June 17, 2024 at 10:00 am Central Daylight Time via the internet as a virtual meeting only (and not in person) at www.virtualshar
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced its second annual private leadership conference from April 30 to May 2 in Houston, Texas.
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Scott J. Saunders, and Kelvin Spears, MD, to its Board of Directors. They replace John Waters, who recently passed away, and Dr. Daniel Stites, who fulfilled his one-year term Board commitment.